Exodus Point Capital Management, LP Assembly Biosciences, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.46 - $2.45 $32,928 - $55,257	-22,554 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.13 - $3.46 $6,675 - $10,843	3,134 Added 16.14%	22,554 $53,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $172,731 - $214,539	-55,010 Reduced 73.91%	19,420 $68,000
Q2 2021 Aug 16, 2021	BUY	$3.8 - $4.56 $226,008 - $271,210	59,476 Added 397.73%	74,430 $289,000
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $9,097 - $13,929	2,101 Added 16.35%	14,954 $69,000

Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $62,594 - $222,228	12,853 New	12,853 $78,000
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $199,549 - $300,846	-20,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $261,870 - $422,240	20,300 New	20,300 $274,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $665M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.